Evidence map›Paper›PMID 29995249›Full record

ReviewDer Internist2018

[From symptom to syndrome using modern software support].

S Köhler

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Internist, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

S KöhlerBerlin Institute of Health (BIH), Anna-Louisa-Karsch-Str. 2, 10178, Berlin, Deutschland. sebastian.koehler@charite.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diagnosing rare diseases can be challenging for clinicians. This article gives an overview on novel approaches, which enable automated phenotype-driven analyses of differential diagnoses for rare diseases as well as genomic variation data of affected individuals. The focus lies on reliable methods for collating clinical phenotypic data and new algorithms for precise and robust assessment of the similarity between phenotypic profiles. The Human Phenotype Ontology project (HPO; www.human-phenotype-ontology.org ) provides an ontology for collating symptoms and clinical phenotypic abnormalities. Using ontologies makes it possible to capture these data in a precise and comprehensive fashion as well as to apply reliable and robust automated analyses. Tools, such as the Phenomizer, enable the algorithmic calculation of similarity values amongst patients or between patients and disease descriptions. Such digital tools represent a solid foundation for differential diagnostic applications. Many rare diseases have a strong genetic component but the analysis of the coding DNA variants in rare disease patients is an enormously complex procedure, which often impedes successful molecular diagnostics. In this situation a combined analysis of the patients HPO-coded phenotypic features and the genomic characteristics of the variants can be of substantial help. In this case the HPO project and the associated algorithms are helpful: it is therefore an important component for phenotype-driven translational research and prioritization of disease-relavant genomic variations.

Indexed as

Biological OntologiesComputational BiologyGene OntologyPhenotypeAlgorithmsGene ExpressionGenomicsHumansModels, BiologicalRare DiseasesSoftwareSyndromeBiomedical ontologyDifferential diagnosisGenotypePhenotypeTranslational medical research

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.